메뉴 건너뛰기




Volumn 33, Issue 1, 2007, Pages 114-118

Pressure-suit combined with pelvic stop-flow: A feasibility study in a bovine model

Author keywords

Experimental surgery; Pharmacokinetics; Pressure suit; Regional cancer treatment; Regional perfusion; Sarcoma

Indexed keywords

CISPLATIN;

EID: 33846381373     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.09.034     Document Type: Article
Times cited : (5)

References (17)
  • 1
    • 0028860207 scopus 로고
    • Regional chemotherapy
    • Aigner K.R. Regional chemotherapy. Reg Cancer Treat 2 (1994) 55-66
    • (1994) Reg Cancer Treat , vol.2 , pp. 55-66
    • Aigner, K.R.1
  • 2
    • 0042829278 scopus 로고    scopus 로고
    • Isolated chemotherapeutic perfusion of the pelvis for advanced rectal cancer
    • Wanebo H.J., Belliveau J., Begossi G., and Levy A. Isolated chemotherapeutic perfusion of the pelvis for advanced rectal cancer. Colorectal Dis 5 5 (2003 Sep) 508-514
    • (2003) Colorectal Dis , vol.5 , Issue.5 , pp. 508-514
    • Wanebo, H.J.1    Belliveau, J.2    Begossi, G.3    Levy, A.4
  • 3
    • 0030147315 scopus 로고    scopus 로고
    • Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon-occlusion technique
    • Wanebo H.J., Chung M.A., Levy A.I., Turk P.S., Vezeridis M.P., and Belliveau J.F. Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon-occlusion technique. Ann Surg Oncol 3 3 (1996 May) 295-303
    • (1996) Ann Surg Oncol , vol.3 , Issue.3 , pp. 295-303
    • Wanebo, H.J.1    Chung, M.A.2    Levy, A.I.3    Turk, P.S.4    Vezeridis, M.P.5    Belliveau, J.F.6
  • 4
    • 4043086430 scopus 로고    scopus 로고
    • Balloon catheter hypoxic abdominal and pelvic perfusion with tumour necrosis factor-alpha, Melphalan and Mitomycin C: a pharmacokinetic study in pigs
    • Van Ijken M.G., De Bruijn E.A., Ten Hagen T.L., De Boeck G., Van Eijck C.H., and Eggermont A.M. Balloon catheter hypoxic abdominal and pelvic perfusion with tumour necrosis factor-alpha, Melphalan and Mitomycin C: a pharmacokinetic study in pigs. Eur J Surg Oncol 30 6 (2004 Aug) 699-707
    • (2004) Eur J Surg Oncol , vol.30 , Issue.6 , pp. 699-707
    • Van Ijken, M.G.1    De Bruijn, E.A.2    Ten Hagen, T.L.3    De Boeck, G.4    Van Eijck, C.H.5    Eggermont, A.M.6
  • 5
    • 0036704332 scopus 로고    scopus 로고
    • Stop-flow technique for loco-regional delivery of antiblastic agents: literature review and personal experience
    • Pilati P., Mocellin S., Miotto D., et al. Stop-flow technique for loco-regional delivery of antiblastic agents: literature review and personal experience. Eur J Surg Oncol 28 5 (2002 Aug) 544-553
    • (2002) Eur J Surg Oncol , vol.28 , Issue.5 , pp. 544-553
    • Pilati, P.1    Mocellin, S.2    Miotto, D.3
  • 6
    • 26444465556 scopus 로고    scopus 로고
    • Bio-chemotherapeutic strategies and the (dis) utility of hypoxic perfusion of liver, abdomen and pelvis using balloon catheter techniques
    • van Ijken M.G., van Etten B., Brunstein F., et al. Bio-chemotherapeutic strategies and the (dis) utility of hypoxic perfusion of liver, abdomen and pelvis using balloon catheter techniques. Eur J Surg Oncol 31 8 (2005 Oct) 807-816
    • (2005) Eur J Surg Oncol , vol.31 , Issue.8 , pp. 807-816
    • van Ijken, M.G.1    van Etten, B.2    Brunstein, F.3
  • 7
    • 0037627840 scopus 로고    scopus 로고
    • Current uses of isolated limb perfusion in the clinic and a model system for new strategies
    • Eggermont A.M., de Wilt J.H., and ten Hagen T.L. Current uses of isolated limb perfusion in the clinic and a model system for new strategies. Lancet Oncol 4 7 (2003 Jul) 429-437
    • (2003) Lancet Oncol , vol.4 , Issue.7 , pp. 429-437
    • Eggermont, A.M.1    de Wilt, J.H.2    ten Hagen, T.L.3
  • 8
    • 0029335961 scopus 로고
    • Intraaortic stop-flow infusion: pharmacokinetic feasibility study of regional chemotherapy for unresectable gastrointestinal cancers
    • Averbach A.M., Stuart O.A., Sugarbaker T.A., et al. Intraaortic stop-flow infusion: pharmacokinetic feasibility study of regional chemotherapy for unresectable gastrointestinal cancers. Ann Surg Oncol 2 4 (1995 Jul) 325-331
    • (1995) Ann Surg Oncol , vol.2 , Issue.4 , pp. 325-331
    • Averbach, A.M.1    Stuart, O.A.2    Sugarbaker, T.A.3
  • 9
    • 0033029966 scopus 로고    scopus 로고
    • A pharmacokinetic model and the clinical pharmacology of cis-platinum, 5-fluorouracil and mitomycin-C in isolated pelvic perfusion
    • Wanebo H.J., and Belliveau J.F. A pharmacokinetic model and the clinical pharmacology of cis-platinum, 5-fluorouracil and mitomycin-C in isolated pelvic perfusion. Cancer Chemother Pharmacol 43 5 (1999) 427-434
    • (1999) Cancer Chemother Pharmacol , vol.43 , Issue.5 , pp. 427-434
    • Wanebo, H.J.1    Belliveau, J.F.2
  • 10
    • 26444471323 scopus 로고    scopus 로고
    • Balloon catheter hypoxic pelvic perfusion with mitomycin C and melphalan for locally advanced tumours in the pelvic region: a phase I-II trial
    • van Ijken M.G., van Etten B., Guetens G., et al. Balloon catheter hypoxic pelvic perfusion with mitomycin C and melphalan for locally advanced tumours in the pelvic region: a phase I-II trial. Eur J Surg Oncol 31 8 (2005 Oct) 897-904
    • (2005) Eur J Surg Oncol , vol.31 , Issue.8 , pp. 897-904
    • van Ijken, M.G.1    van Etten, B.2    Guetens, G.3
  • 11
    • 0031786730 scopus 로고    scopus 로고
    • Pharmacokinetics of mitomycin C in pelvic stopflow infusion and hypoxic pelvic perfusion with and without hemofiltration: a pilot study of patients with recurrent unresectable rectal cancer
    • Guadagni S., Aigner K.R., Palumbo G., et al. Pharmacokinetics of mitomycin C in pelvic stopflow infusion and hypoxic pelvic perfusion with and without hemofiltration: a pilot study of patients with recurrent unresectable rectal cancer. J Clin Pharmacol 38 10 (1998 Oct) 936-944
    • (1998) J Clin Pharmacol , vol.38 , Issue.10 , pp. 936-944
    • Guadagni, S.1    Aigner, K.R.2    Palumbo, G.3
  • 12
    • 4043097773 scopus 로고    scopus 로고
    • Stop-flow technique for loco-regional delivery of high dose chemotherapy in the treatment of advanced pelvic cancers
    • Strocchi E., Iaffaioli R.V., Facchini G., et al. Stop-flow technique for loco-regional delivery of high dose chemotherapy in the treatment of advanced pelvic cancers. Eur J Surg Oncol 30 6 (2004 Aug) 663-670
    • (2004) Eur J Surg Oncol , vol.30 , Issue.6 , pp. 663-670
    • Strocchi, E.1    Iaffaioli, R.V.2    Facchini, G.3
  • 13
    • 20244373290 scopus 로고    scopus 로고
    • Hypoxic antiblastic stop-flow perfusion: clinical outcome and pharmacokinetic findings
    • Miotto D., Miotto D., Bertolo S., et al. Hypoxic antiblastic stop-flow perfusion: clinical outcome and pharmacokinetic findings. J Chemother 16 Suppl. 5 (2004 Nov) 44-47
    • (2004) J Chemother , vol.16 , Issue.SUPPL. 5 , pp. 44-47
    • Miotto, D.1    Miotto, D.2    Bertolo, S.3
  • 14
    • 0037331366 scopus 로고    scopus 로고
    • Hypoxic pelvic and limb perfusion with melphalan and mitomycin C for recurrent limb melanoma: a pilot study
    • Guadagni S., Santinami M., Patuzzo R., et al. Hypoxic pelvic and limb perfusion with melphalan and mitomycin C for recurrent limb melanoma: a pilot study. Melanoma Res 13 1 (2003 Feb) 51-58
    • (2003) Melanoma Res , vol.13 , Issue.1 , pp. 51-58
    • Guadagni, S.1    Santinami, M.2    Patuzzo, R.3
  • 15
    • 0035154896 scopus 로고    scopus 로고
    • Hypoxic pelvic perfusion with mitomycin C using a simplified balloon-occlusion technique in the treatment of patients with unresectable locally recurrent rectal cancer
    • Guadagni S., Fiorentini G., Palumbo G., et al. Hypoxic pelvic perfusion with mitomycin C using a simplified balloon-occlusion technique in the treatment of patients with unresectable locally recurrent rectal cancer. Arch Surg 136 1 (2001 Jan) 105-112
    • (2001) Arch Surg , vol.136 , Issue.1 , pp. 105-112
    • Guadagni, S.1    Fiorentini, G.2    Palumbo, G.3
  • 16
    • 0031744292 scopus 로고    scopus 로고
    • TNF alpha in isolated perfusion systems: success in the limb, developments for the liver credits, debits and future perspectives
    • Eggermont A.M. TNF alpha in isolated perfusion systems: success in the limb, developments for the liver credits, debits and future perspectives. Anticancer Res 18 5D (1998 Sep-Oct) 3899-3905
    • (1998) Anticancer Res , vol.18 , Issue.5 D , pp. 3899-3905
    • Eggermont, A.M.1
  • 17
    • 25444508401 scopus 로고    scopus 로고
    • Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-alpha be better?
    • Bonvalot S., Laplanche A., Lejeune F., et al. Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-alpha be better?. Ann Oncol 16 7 (2005 Jul) 1061-1068
    • (2005) Ann Oncol , vol.16 , Issue.7 , pp. 1061-1068
    • Bonvalot, S.1    Laplanche, A.2    Lejeune, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.